SWA
ABBV icon

Strategies Wealth Advisors’s AbbVie ABBV Stock Holding History

Strategies Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Sell
1,277
-5
-0.4% -$1.08K 0.03% 153
2026
Q1 		$279K Sell
1,282
-877
-41% -$195K 0.03% 143
2025
Q4 		$493K Buy
2,159
+99
+5% +$22.6K 0.05% 99
2025
Q3 		$477K Hold
2,060
– – 0.05% 112
2025
Q2 		$382K Sell
2,060
-14
-0.7% -$2.6K 0.04% 121
2025
Q1 		$435K Buy
+2,074
New +$403K 0.05% 108

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Strategies Wealth Advisors's ABBV Position: Q2 2026 in Review

Strategies Wealth Advisors reduced its AbbVie (ABBV) stake by 0.39% in Q2 2026, selling an estimated $1.08K and leaving 1,277 shares worth $321K. The position accounts for 0.03% of the portfolio, ranked #153.

Strategies Wealth Advisors first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $493K in Q4 2025. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Strategies Wealth Advisors held 1,277 shares of AbbVie worth $321K as of Q2 2026.
  • Strategies Wealth Advisors sold 5 AbbVie shares in Q2 2026, an estimated $1.08K.
  • AbbVie made up 0.03% of Strategies Wealth Advisors's portfolio in Q2 2026, its #153 holding.
  • Strategies Wealth Advisors first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • Strategies Wealth Advisors's AbbVie position peaked at $493K in Q4 2025.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Strategies Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.